High HDAC9 gene expression in B-lymphoproliferative disorders, including B-NHL cell lines and patient samples, has pointed to a potential role in these diseases (Petrie et al., 2003; Sun et al., 2011). Here, HDAC9 is linked to non-Hodgkin lymphoma.